目的评价超声导向下经皮肝穿刺瘤内注射无水酒精(percutaneous ethanol injection,PEI),在肝癌术后复发病人中的治疗效果和应用价值。
基于2个网页-相关网页
... 塞术(transcatheter arterial chemoembolization,TACE)、经皮穿刺瘤内注射无水酒精(percutaneous ethanol injection,PEI)是国内外公认治疗肝癌的首选非手术方法,肝癌的血供95%~99%来自肝动脉,这些方法或是阻断肿瘤血供,..
基于1个网页-相关网页
穿刺瘤内注射无水酒精 percutaneous ethanol injection ; PEI
方法通过B超探头穿刺架引导经皮肝穿刺瘤内注射无水酒精治疗肝癌31例,64个肝癌结节,共治疗272次。
Methods Cured hepatocellular carcinoma 31 cases by percutaneous ethanol injection under B-ultrasonic guidance, 64 nodes of hepatocellular carcinoma, amounted to 272 times.
探索介入化疗、局部注射TIL、瘤内无水酒精注射综合治疗晚期肝癌的疗效。
To probe into curative effect of comprehensively treating hepatocellular carcinoma by interventional chemotherapy, locally injecting TIL and injecting absolute alcohol into tumor.
结论经皮肝穿刺无水酒精瘤内注射可作为原发性小肝癌一种非手术治疗方法,手术前PEIT可降低患者术后复发率。
Conclusion PEIT can be used as a non-invasive treatment for SPLC, and preoperative PEIT appears to be helpful in reducing recurrence of postoperative liver cancer.
应用推荐